Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 782,30 DKK | +0,84% |
|
+4,95% | +12,06% |
| 03/12 | Novo Nordisk's India-afdeling wil Wegovy naar verluidt eerder lanceren | MT |
| 03/12 | Sectorupdate: Gezondheidszorgaandelen dalen dinsdag premarket | MT |
ETF's gepositioneerd op Novo Nordisk A/S
| Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
|---|---|---|---|---|
| 21.31% | 203 M€ | +13,99% | ||
| 10.45% | 4 M€ | +19,51% | ||
| 5.40% | 20 M€ | +16,27% | - | |
| 3.95% | 4 M€ | -.--% | - | |
| 3.91% | 5 M€ | +10,09% | - | |
| 3.91% | 14 M€ | +5,66% | - | |
| 3.78% | 6 M€ | -.--% | ||
| 3.09% | 12 M€ | +15,09% | - | |
| 3.02% | 6 M€ | -.--% | - | |
| 2.87% | 29 M€ | +8,37% | - | |
| 2.53% | 469 M€ | -1,75% | ||
| 2.53% | 3 859 M€ | +18,82% | ||
| 2.22% | 3 M€ | +11,67% | - | |
| 1.91% | 2 M€ | -.--% | - | |
| 1.91% | 2 M€ | +9,19% | - | |
| 1.67% | 10 M€ | -3,35% | - | |
| 1.60% | 10 M€ | +6,14% | - | |
| 1.31% | 273 M€ | +11,32% | ||
| 1.04% | 276 M€ | +11,40% | - | |
| 1.03% | 8 M€ | +5,78% | - | |
| 1.02% | 33 076 M€ | +13,38% | - | |
| 0.89% | 1 005 M€ | +9,74% | ||
| 0.79% | 284 M€ | -.--% | ||
| 0.76% | 23 M€ | -.--% | - | |
| 0.76% | 786 M€ | -.--% | ||
| 0.75% | 206 M€ | -.--% | ||
| 0.70% | 7 M€ | +0,11% | - | |
| 0.64% | 274 M€ | +15,64% | - | |
| 0.64% | 216 M€ | +14,54% | - | |
| 0.64% | 453 M€ | -.--% | ||
| 0.57% | 772 M€ | +17,85% | ||
| 0.56% | 607 M€ | -0,19% | ||
| 0.56% | 1 166 M€ | +0,26% | - |
Werknemers
71.880
Sector
Farmaceutische producten
Agenda
05-02-2025
- Q4 2024 Cijferpublicaties
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
24
Laatste slotkoers
782,30DKK
Gemiddelde koersdoel
942,00DKK
Spread / Gemiddelde doel
+20,41%
Kwartaalomzet - Afwijkingspercentage
- Beurs
- Aandelen
- Koers NOVO B
- ETF's Novo Nordisk A/S
